(SOLV) Solvac S.A. - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003545531
SOLV: Specialty Polymers, Composite Materials, Soda Ash, Peroxides, Silica, Coatings
Solvac S.A. is a Belgium-based advanced materials and specialty chemicals company that develops and manufactures a diverse range of products, including specialty polymers, composite materials, soda ash, peroxides, silica, and coatings. These materials are used across various industries such as construction, automotive, electronics, and industrial manufacturing. Established in 1983 and headquartered in Brussels, Belgium, Solvac S.A. has built a reputation for delivering high-performance solutions tailored to meet specific customer requirements. The companys product portfolio is designed to enhance efficiency, durability, and sustainability in industrial applications. Web URL: https://www.solvac.be
From a technical perspective, Solvac S.A. (BR:SOLV) is currently trading at 94.60, above its 20-day simple moving average (SMA) of 88.92 but below its 50-day SMA of 93.44. The stock is notably below its 200-day SMA of 98.59, indicating a potential downtrend in the longer term. The average true range (ATR) of 2.63 reflects moderate volatility. The stocks average 20-day volume is 1028, suggesting limited trading activity compared to larger-cap peers.
From a fundamental standpoint, Solvac S.A. has a market capitalization of 1868.18M EUR, with a price-to-earnings (P/E) ratio of 17.84, indicating a moderately valued stock relative to its earnings. The price-to-book (P/B) ratio of 0.73 suggests that the stock may be undervalued relative to its book value. However, the return on equity (RoE) of 1.18% is relatively low, pointing to suboptimal profitability compared to industry peers.
Forecast: Based on the technical and fundamental data, Solvac S.A. (BR:SOLV) is expected to remain range-bound in the near term, with potential downside risks due to its position below the 200-day SMA. The low ATR and limited trading volume suggest reduced market interest. On the fundamental side, while the P/B ratio may attract value investors, the low RoE and lack of forward P/E guidance could limit upside momentum. Overall, the stock is likely to experience a neutral to bearish trend in the short to medium term.
Additional Sources for SOLV Stock
SOLV Stock Overview
Market Cap in USD | 2,113m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception |
SOLV Stock Ratings
Growth Rating | 7.47 |
Fundamental | 13.3 |
Dividend Rating | 30.7 |
Rel. Strength | -12.1 |
Analysts | - |
Fair Price Momentum | 80.34 EUR |
Fair Price DCF | 128.47 EUR |
SOLV Dividends
Dividend Yield 12m | 3.64% |
Yield on Cost 5y | 4.68% |
Annual Growth 5y | -8.52% |
Payout Consistency | 94.5% |
SOLV Growth Ratios
Growth Correlation 3m | -86% |
Growth Correlation 12m | -62.8% |
Growth Correlation 5y | 39.3% |
CAGR 5y | 4.07% |
CAGR/Max DD 5y | 0.13 |
Sharpe Ratio 12m | -0.20 |
Alpha | -23.84 |
Beta | 0.344 |
Volatility | 26.47% |
Current Volume | 1.7k |
Average Volume 20d | 1k |
As of May 09, 2025, the stock is trading at EUR 91.00 with a total of 1,666 shares traded.
Over the past week, the price has changed by -4.21%, over one month by +5.08%, over three months by -11.22% and over the past year by -16.69%.
Neither. Based on ValueRay Fundamental Analyses, Solvac S.A. is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SOLV as of May 2025 is 80.34. This means that SOLV is currently overvalued and has a potential downside of -11.71%.
Solvac S.A. has no consensus analysts rating.
According to ValueRays Forecast Model, SOLV Solvac S.A. will be worth about 87.1 in May 2026. The stock is currently trading at 91.00. This means that the stock has a potential downside of -4.27%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 149.8 | 64.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 87.1 | -4.3% |